The tolerability issue of generic imatinib in patients with chronic myeloid leukemia <i>(Comment on Adi J. Klil-Drori et al., Haematologica 2019;104(7):e293)</i>.


Creative Commons License

Eskazan A. E., Soysal T.

Haematologica, cilt.104, 2019 (SCI-Expanded, Scopus)